COVID-19 In Vitro Diagnostic Medical Device - detail | COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Bfast [SARS-CoV-2] RT-PCR kit - 48

Manufactured by BforCure, France - https://www.bforcure.com/

Device identification number

5729

CE Marking

✓Yes

HSC common list (RAT)

×No

Format

Lab-based

Physical Support

Microplate

Target type

Nucleic acid

Targets

envelope protein/gene, nucleocapsid protein/gene

Specimen

Nasopharyngeal swab, Saliva

Cross-reactivity (pathogens tested)

Chlamydia Pneumoniae, Influenza A, Influenza B, Other (Legionella pneumophila, Streptococcus pneumoniae, Streptococcus pyogenes, Legionella anisa, Legionella longbeachae, Legionella cherii, Legionella jordanis, Pseudomonas aeruginosa, Staphylococcus aureus), Respiratory Syncytial V (RSV) Type A, Respiratory Syncytial V (RSV) Type B

Pathogens detected

SARS-CoV-2

Lineages detected

A.23.1, AT.1, B.1.1.529 (Omicron), B.1.1.7 (Alpha), B.1.351 (Beta), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.525 (Eta), B.1.526 (Iota), B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3, B.1.621 (Mu), C.36, C.37 (Lambda), P.1 (Gamma), P.2 (Zeta), P.3 (Theta),

Commercial Status

Commercialised

Last Update

2022-10-25 10:06:19 CET

Assay Type

Nucleic acid-PCR

Rapid Diagnostic

N.A.

Self Test

Reader Required

Yes

Subcategory

Sample preparation

Method

RT-PCR

Measurement

N.A.

Subclass

N.A.

Detection Principle

Fluorescence

LOD

100 copies/reaction

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements